Literature DB >> 9880025

The large T antigen of simian virus 40 binds and inactivates p53 but not p73.

M Dobbelstein1, J Roth.   

Abstract

The p73 proteins alpha and beta were identified based on their similarity to the tumour suppressor gene product p53. p53 and the p73 proteins activate transcription from p53-responsive promoters. The large T antigen of simian virus 40 (SV40) forms a specific complex with p53 and inhibits p53-mediated transcription. Here we show that the large T antigens from SV40 and JC virus strongly reduce the transcriptional activity of p53 but do not detectably affect the ability of the p73 proteins to transactivate. p53 but not the p73 proteins associate with SV40 T antigen in vitro. Finally, p53 colocalizes with a cytoplasmic mutant of SV40 T antigen, whereas both variants of p73 fail to colocalize with cytoplasmic T antigen. These results indicate that T antigen selectively binds and inactivates p53 but does not detectably affect the p73 proteins.

Entities:  

Mesh:

Substances:

Year:  1998        PMID: 9880025     DOI: 10.1099/0022-1317-79-12-3079

Source DB:  PubMed          Journal:  J Gen Virol        ISSN: 0022-1317            Impact factor:   3.891


  14 in total

1.  The human p73 promoter: characterization and identification of functional E2F binding sites.

Authors:  Ratnam S Seelan; Meredith Irwin; Petra van der Stoop; Chiping Qian; William G Kaelin; Wanguo Liu
Journal:  Neoplasia       Date:  2002 May-Jun       Impact factor: 5.715

2.  E1B 55-kilodalton oncoproteins of adenovirus types 5 and 12 inactivate and relocalize p53, but not p51 or p73, and cooperate with E4orf6 proteins to destabilize p53.

Authors:  S Wienzek; J Roth; M Dobbelstein
Journal:  J Virol       Date:  2000-01       Impact factor: 5.103

3.  Release of severe acute respiratory syndrome coronavirus nuclear import block enhances host transcription in human lung cells.

Authors:  Amy C Sims; Susan C Tilton; Vineet D Menachery; Lisa E Gralinski; Alexandra Schäfer; Melissa M Matzke; Bobbie-Jo M Webb-Robertson; Jean Chang; Maria L Luna; Casey E Long; Anil K Shukla; Armand R Bankhead; Susan E Burkett; Gregory Zornetzer; Chien-Te Kent Tseng; Thomas O Metz; Raymond Pickles; Shannon McWeeney; Richard D Smith; Michael G Katze; Katrina M Waters; Ralph S Baric
Journal:  J Virol       Date:  2013-01-30       Impact factor: 5.103

4.  Mdm-2 and ubiquitin-independent p53 proteasomal degradation regulated by NQO1.

Authors:  Gad Asher; Joseph Lotem; Leo Sachs; Chaim Kahana; Yosef Shaul
Journal:  Proc Natl Acad Sci U S A       Date:  2002-09-13       Impact factor: 11.205

5.  ASPP1 and ASPP2: common activators of p53 family members.

Authors:  Daniele Bergamaschi; Yardena Samuels; Boquan Jin; Sai Duraisingham; Tim Crook; Xin Lu
Journal:  Mol Cell Biol       Date:  2004-02       Impact factor: 4.272

6.  Detection and typing of BKV, JCV, and SV40 by multiplex nested polymerase chain reaction.

Authors:  Massimiliano Bergallo; Cristina Costa; Samuela Margio; Francesca Sidoti; Giuseppe P Segoloni; Alessandro Negro Ponzi; Rossana Cavallo
Journal:  Mol Biotechnol       Date:  2007-03       Impact factor: 2.695

7.  SHP-2 tyrosine phosphatase inhibits p73-dependent apoptosis and expression of a subset of p53 target genes induced by EGCG.

Authors:  A R M Ruhul Amin; Vijay S Thakur; Rajib K Paul; Gen Sheng Feng; Cheng-Kui Qu; Hasan Mukhtar; Munna L Agarwal
Journal:  Proc Natl Acad Sci U S A       Date:  2007-03-16       Impact factor: 11.205

Review 8.  Modulation of p53 during bacterial infections.

Authors:  Christine Siegl; Thomas Rudel
Journal:  Nat Rev Microbiol       Date:  2015-11-09       Impact factor: 60.633

9.  Vy-PER: eliminating false positive detection of virus integration events in next generation sequencing data.

Authors:  Michael Forster; Silke Szymczak; David Ellinghaus; Georg Hemmrich; Malte Rühlemann; Lars Kraemer; Sören Mucha; Lars Wienbrandt; Martin Stanulla; Andre Franke
Journal:  Sci Rep       Date:  2015-07-13       Impact factor: 4.379

10.  Stochastic and Deterministic Models of Cellular p53 Regulation.

Authors:  Gerald B Leenders; Jack A Tuszynski
Journal:  Front Oncol       Date:  2013-04-02       Impact factor: 6.244

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.